BioNTech: Could Covid vaccine technology crack cancer?
They are the husband and wife team behind one the most successful Covid vaccines, yet in the UK they are barely known.
Professors Ugur Sahin and Ozlem Tureci co-founded the German company BioNTech in 2008, exploring new technology involving messenger RNA (mRNA), to treat cancer.
When the pandemic struck they partnered with Pfizer to use the same approach to create a Covid vaccine. Now the doctors are hopeful it could lead to new treatments for melanoma, bowel cancer and other tumour types. BioNTech has several trials in progress, including one where patients are given a personalised vaccine, to prompt their immune system to attack their disease.